# Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use

> **NCT07452146** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 64 (estimated)

## Conditions studied

- Alcohol Use Disorder
- Inflammatory Response
- Craving

## Interventions

- **DRUG:** Endotoxin
- **OTHER:** Placebo saline

## Key facts

- **NCT ID:** NCT07452146
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-06
- **Final completion:** 2028-07
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07452146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07452146, "Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07452146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*